Allogene Therapeutics, Inc. ALLO
0.63 USD -0.04 (-5.88%)
Regular-session close
0.63 +0.01 +1.12%
After hours · Nov 20, 7:37 PM ET
0.6192 Day range 0.67
0.6277 52-week range 3.06
- YTD
- -54.18%
- 1 year
- -49.38%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 209.31M | 273.22M | 327.83M | 335.69M | 294.28M | |
| 150.15M | 192.30M | 242.91M | 256.39M | 220.18M | |
| 56.78M | 65.20M | 71.67M | 79.31M | 74.11M | |
| -209.31M | -273.20M | -327.74M | -335.54M | -180.19M | |
| 1.07M | 181.00K | 0 | 0 | 0 | |
| -190.89M | -257.59M | -327.26M | -340.41M | -182.05M | |
| -190.89M | -257.59M | -327.26M | -340.41M | -182.05M | |
| -190.89M | -257.59M | -327.26M | -340.41M | -182.05M | |
| -190.89M | -257.59M | -327.26M | -340.41M | -182.05M | |
| -0.87 | -1.32 | -2.09 | -2.38 | -1.34 | |
| -0.87 | -1.32 | -2.09 | -2.38 | -1.34 | |
| -0.87 | -1.32 | -2.09 | -2.38 | -1.34 | |
| -189.81M | -256.97M | -327.26M | -340.41M | -182.05M | |
| -189.81M | -256.97M | -327.26M | -340.41M | -182.05M | |
| 220.62M | 194.81M | 156.93M | 143.15M | 135.82M | |
| 220.62M | 194.81M | 156.93M | 143.15M | 135.82M |
